Main news

Appeals to “stay at home” during COVID-19 do not apply to heart attacks People experiencing heart attacks should immediately phone the emergency services – even during the COVID-19 pandemic. The urgent call from the European Society of Cardiology (ESC) comes as hospitals in Europe and beyond report dramatic reductions in heart attack admissions.

Vitamin K Antagonists and Osteoporotic Fractures: Insights From Comparisons With the NOACs Vitamin K antagonists (VKAs; warfarin mostly, but also acenocoumarol, phenprocoumon, phenindione, and fluindione) have been a cornerstone in medicine as the first and the only available oral anticoagulants (OACs) for clinical use for over half a century.

High haemoglobin A1c level is a possible risk factor for ventricular fibrillation in sudden cardiac arrest among non-diabetic individuals in the general population This study aimed to establish whether higher levels of glycated haemoglobin (HbA1c) are associated with increased sudden cardiac arrest (SCA) risk in non-diabetic individuals.

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The most distinctive comorbidities of 32 non-survivors from a group of 52 intensive care unit patients with novel coronavirus disease 2019 (COVID-19) in the study by Xiaobo Yang and colleagues were cerebrovascular diseases (22%) and diabetes (22%).

Mitral Regurgitation Management Focused Update: Key Points This is an update to the 2017 American College of Cardiology (ACC) expert consensus decision pathway (ECDP) on the management of mitral regurgitation (MR).

Europe to personalise prevention of second heart attacks Cardiovascular disease (CVD) is the top cause of death in Europe and worldwide, accounting for 47% of deaths in women and 39% of deaths in men.1 CVD costs the EU more than €210 billion a year,2 a sum expected to escalate with an ageing population and the cost of novel therapies.

Eating meat, including chicken, linked to heart disease risk in study Eating meat has been linked to heart disease in the latest study to suggest the food could pose some risk to our health.

Periodontitis increases the risk of suffering from future atherosclerotic cardiovascular disease It was already known, but so far there was no rigorous and exhaustive report that corroborated the link between periodontitis and the future risk of developing atherosclerotic cardiovascular disease. Now two of the international reference entities in the field of periodontal and cardiovascular health, the European Federation of Periodontics (VET) and the World Heart Federation (WHF), publish a consensus powerful that leaves no room for doubt.

PARTNER 2A Intermediate-Risk TAVR Five-Year Results Hit Print Late outcomes of transcatheter aortic valve replacement (TAVR) in the PARTNER 2A trial are now enshrined in the peer-reviewed literature.

New report reveals the role of physical activity in preventing and treating cardiovascular diseases The European Heart Network, in collaboration with the WHO European Office for the Prevention and Control of Noncommunicable Diseases, has published an important report on physical activity policies for cardiovascular health. Each year, cardiovascular diseases cause 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. Physical inactivity increases the risk of cardiovascular diseases by more than 20%.

ACP Revises Standard on Cardiorespiratory Death Determination
ACP Revises Standard on Cardiorespiratory Death Determination The American College of Physicians (ACP) has issued a new position paper on determination of death that includes a clarification to the 1981 Uniform Determination of Death Act (UDDA), but otherwise reaffirms the current standards.

AHA Updates CPR Guidelines on Cardiac Arrest After Poisoning
AHA Updates CPR Guidelines on Cardiac Arrest After Poisoning The American Heart Association (AHA) has released a focused update on managing patients with cardiac arrest or life-threatening toxicity due to poisoning. The update reflects treatment advances and new knowledge, including the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for patients whose condition is refractory to poison antidotes and other therapies.

Editorial Activity

cardiology book

Marijuana may cause the same cardiovascular damage as cigarettes
Marijuana may cause the same cardiovascular damage as cigarettes More than two million Americans with heart disease are using or have used marijuana - and it could put them at risk of dangerously heavy bleeding and other complications, a new study warns.

Don't Stop the Statin! Christopher P. Cannon
Don't Stop the Statin! Christopher P. Cannon Lipid lowering with statins is one of the most beneficial therapies in cardiovascular medicine, with evidence from hundreds of randomized clinical trials, including >25 large cardiovascular outcomes trials in the Cholesterol Treatment Trialists (CTT) collaboration.

Expert point of view
Expert point of view Strategies to Overcome Residual Risk During Statins Era

PreHT 2020|Vilnius | Lithuania | 2-5 April 2020 7th International Conference on Prehypertension, Hypertension, Metabolic Disorders and Cardiovascular Disease (PreHT 2020)

FDA Clears Architect Stat High-Sensitivity Troponin Test for MI
FDA Clears Architect Stat High-Sensitivity Troponin Test for MI The US Food and Drug Administration (FDA) has approved the Architect Stat (Abbott Laboratories) high-sensitivity troponin-I assay, which can detect myocardial infarction (MI) faster and more accurately than other troponin tests, according to the company.

World Heart Day 2019
World Heart Day 2019 This year on World Heart Day, as part of our mission to ensure heart health equity for all, we want to create a global community of Heart Heroes … people from all walks of life who are acting now to live longer, better, heart-healthy lives by making a promise: for MY HEART, for YOUR HEART, for ALL OUR HEARTS.

ESC 2019: Wrap up in Russian - Live and interactive programme
ESC 2019: Wrap up in Russian - Live and interactive programme In collaboration with the Russian Society of Cardiology, this programme is designed to present a selection of scientific highlights from ESC Congress and discuss clinical practice implications with experts.